6-K 1 tm262757d1_6k.htm FORM 6-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

For the month of January 2026

Commission file number: 001-32749

FRESENIUS MEDICAL CARE AG

(Translation of registrant's name into English)

Else-Kröner Strasse 1

61346 Bad Homburg

Germany

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x               Form 40-F ¨

EXHIBITS

The following exhibits are being furnished with this Report:

Exhibit 99.1	Convenience translation of information disclosed on January 9, 2026 according to Article 17 Market Abuse Regulation (MAR) of the Regulation (EU) No 596/2014.

Exhibit 99.2	Press Release issued on January 9, 2026.

The exhibits furnished with this report do not, individually or in the aggregate, constitute an offer to purchase or a solicitation of any offer to sell any securities.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

DATE: January 12, 2026

	Fresenius Medical Care AG


	By:	/s/ Helen Giza
	Name:	Helen Giza
	Title:	Chief Executive Officer and Chair of the Management Board

	By:	/s/ Martin Fischer
	Name:	Martin Fischer
	Title:	Chief Financial Officer and member of the Management Board

SEC Form 6-K filed by Fresenius Medical Care AG